| Literature DB >> 25617190 |
Sabine Dittrich1, Sayaphet Rattanavong2, Sue J Lee3, Phonepasith Panyanivong2, Scott B Craig4, Suhella M Tulsiani5, Stuart D Blacksell3, David A B Dance1, Audrey Dubot-Pérès6, Amphone Sengduangphachanh2, Phonelavanh Phoumin2, Daniel H Paris3, Paul N Newton7.
Abstract
BACKGROUND: Scrub typhus (caused by Orientia tsutsugamushi), murine typhus (caused by Rickettsia typhi), and leptospirosis are common causes of febrile illness in Asia; meningitis and meningoencephalitis are severe complications. However, scarce data exist for the burden of these pathogens in patients with CNS disease in endemic countries. Laos is representative of vast economically poor rural areas in Asia with little medical information to guide public health policy. We assessed whether these pathogens are important causes of CNS infections in Laos.Entities:
Mesh:
Year: 2015 PMID: 25617190 PMCID: PMC4547322 DOI: 10.1016/S2214-109X(14)70289-X
Source DB: PubMed Journal: Lancet Glob Health ISSN: 2214-109X Impact factor: 26.763
Clinical and demographic data of patients with suspected CNS infections by pathogen group
| Age (years) | 24 (0–85; 1) | 14 (0·1–65) | 29 (0·3–70) | 0·051 | 16 (0·3–76) | 0·412 | 25 (0·2–72) | 0·058 |
| Age <15 years | 371/1111 (33%) | 21/42 (50%) | 7/28 (25%) | 0·048 | 14/31 (45%) | 0·813 | 7/31 (23%) | 0·028 |
| Male | 696/1111 (63%) | 26/ 42 (62%) | 18/28 (67%) | 1 | 22/31 (71%) | 0·464 | 22/31 (71%) | 0·464 |
| Farmers (if aged >15 years) | 110/614 (18%) | 6/18 (33%) | 2/18 (11%) | 0·228 | 2/13 (15%) | 0·412 | 6/19 (32%) | 1 |
| Preadmission antibiotic use | 619/992 (62%) | 23/36 (64%) | 17/25 (68%) | 0·790 | 25/29 (86%) | 0·051 | 17/29 (59%) | 0·798 |
| Fever at admission (>38°C) | 990/1102 (90%) | 41/42 (98%) | 27/27 (100%) | 1 | 31/31 (100%) | 1 | 30/31 (97%) | 1 |
| Days of fever | 4 (0–210; 10) | 3 (0-30) | 4 (1–30; 1) | 0·053 | 7 (1–15; 1) | 0·0001 | 4 (0–120) | 0·144 |
| Headache | 820/932 (88%) | 21/25 (84%) | 24/25 (96%) | 0·349 | 24/27 (89%) | 0·698 | 28/29 (97%) | 0·170 |
| Vomiting | 523/1110 (47%) | 21/42 (50%) | 12/28 (15%) | 0·629 | 18/30 (60%) | 0·475 | 16/31 (52%) | 1 |
| Convulsions | 334/1108 (30%) | 18/41 (44%) | 7/28 (25%) | 0·132 | 8/31 (26%) | 0·141 | 6/31 (19%) | 0·043 |
| Stiff neck | 608/1107 (55%) | 29/42 (69%) | 14/28 (50%) | 0·136 | 20/30 (67%) | 1 | 15/31 (48%) | 0·093 |
| Skin rash | 117/1107 (11%) | 1/42 (2%) | 3/28 (11%) | 0·294 | 6/30 (20%) | 0·018 | 2/31 (7%) | 0·571 |
| Hearing loss | 51/931 (6%) | 1/25 (4%) | 0/25 (0%) | 1 | 3/27 (11%) | 0·611 | 2/29 (7%) | 1 |
| Photophobia | 29/982 (3%) | 1/41 (2%) | 0/28 (0%) | 1 | 4/30 (13%) | 0·155 | 1/31 (3·2) | 1 |
| Eschar | 21/1105 (2%) | 0/42 (0%) | 1/28 (4%) | 0·400 | 2/30 (7%) | 0·170 | 0/31 (0%) | 1 |
| Tachypnoea | 585/1081 (54%) | 25/42 (60%) | 20/28 (71%) | 0·445 | 20/31 (65%) | 0·808 | 21/31 (68%) | 0·624 |
| Peripheral neurological abnormalities | 23/970 (2%) | 0/41 (0%) | 0/26 (0%) | 1 | 0/22 (0) | 1 | 3/27 (11%) | 0·058 |
| GCS | 14 (3–15; 61) | 13 (3-15; 3) | 14 (5-15; 1) | 0·442 | 15 (3–15; 1) | 0·013 | 15 (5–15) | 0·274 |
| GCS <15 | 531/1051 (51%) | 26/39 (67%) | 14/27 (52%) | 0·306 | 11/30 (37%) | 0·016 | 15/31 (48%) | 0·148 |
| Meningitis | 709/1093 (65%) | 33/42 (79%) | 19/28 (68%) | 0·405 | 25/31 (81%) | 1 | 21/31 (68%) | 0·419 |
| Meningitis (>38·5°C) | 403/959 (42%) | 25/38 (66%) | 7/25 (28%) | 0·005 | 19/28 (68%) | 1 | 14/29 (48%) | 0·212 |
| Acute encephalitis syndrome | 610/1093 (56%) | 33/42 (79%) | 16/28 (57%) | 0·067 | 15/31 (48%) | 0·012 | 16/31 (52%) | 0·023 |
| Meningitis and acute encephalitis syndrome | 521/1093 (48%) | 29/42 (69%) | 16/28 (57%) | 0·322 | 14/31 (45%) | 0·055 | 14/31 (45%) | 0·055 |
| Died | 236/876 (27%) | 13/39 (33%) | 7/26 (27%) | 0·784 | 3/22 (14%) | 0·132 | 3/23 (13%) | 0·132 |
| Opening pressure (cm H2O) | 20 (0–41; 120) | 24 (7·8–41; 5) | 17 (9-40) | 0·162 | 22 (8–41; 5) | 0·610 | 19 (10–35·5; 2) | 0·458 |
| Turbid | 145/1000 (15%) | 21/40 (53%) | 1/25 (4%) | <0·0001 | 4/25 (16·0) | 0·004 | 3/30 (10%) | <0·0001 |
| Total white cell count (mm3) | 30 (0–17 200; 104) | 410 (0–9600) | 10 (0–605; 2) | 0·0001 | 68 (0–653; 5) | 0·0001 | 88 (0–5325; 1) | 0·002 |
| Neutrophils (mm3) | 14·8 (0–17 200; 126) | 240 (0–9600) | 5·1 (0–545; 2) | 0·0001 | 44·8 (0–535; 6) | 0·0004 | 30 (0–4805; 1) | 0·0004 |
| Number of neutrophils ≥1/mm3 | 731/986 (74·1) | 39/42 (93%) | 17/28 (61%) | 0·003 | 22/25 (88%) | 0·664 | 23/30 (77%) | 0·019 |
| Lymphocytes (mm3) | 10 (0–6976; 134) | 25 (0–3515) | 5 (0–340; 2) | 0·005 | 21 (0–445; 6) | 0·236 | 21·8 (0–833; 1) | 0·352 |
| Number of lymphocytes >5/mm3 | 558/978 (57·1) | 32/42 (76%) | 10/26 (39%) | 0·004 | 18/25 (72%) | 0·775 | 19/30 (63%) | 0·296 |
| Neutrophil to lymphocyte ratio | 1 (0–174; 136) | 2·7 (0–44; 4) | 1 (0–9; 5) | 0·0001 | 1·9 (0·1–19; 9) | 0·024 | 1 (0–9; 4) | 0·004 |
| Lactate >4 mmol/L | 255/780 (33%) | 30/35 (86%) | 7/21 (33%) | <0·0001 | 5/21 (24%) | <0·0001 | 14/23 (61%) | <0·0001 |
| Glucose <2·5 mmol/L | 217/780 (28%) | 23/35 (66%) | 5/21 (24%) | 0·005 | 3/21 (15%) | <0·0001 | 7/23 (30%) | 0·015 |
| CSF to blood glucose ratio <0·5 | 380/780 (49%) | 32/35 (91%) | 8/21 (38%) | <0·0001 | 9/21 (43%) | <0·0001 | 8/23 (35%) | <0·0001 |
| Protein >0·4 g/L | 600/947 (63%) | 32/36 (89%) | 10/22 (46%) | 0·001 | 17/22 (77%) | 0·278 | 13/25 (53%) | 0·002 |
Data are median (range; missing) or n/N (%). GCS=Glasgow coma scale. CSF=cerebrospinal fluid. Continuous variables were compared with the Mann-Whitney U test and dichotomous variables with the Fisher's exact test. We included only single infections detected either by culture, molecular diagnostic, or four-fold antibody titre rise between admission and convalescent samples. We calculated p values by comparing patients with Rickettsia typhi or Rickettsia spp, Orientia tsutsugamushi, and Leptospira spp, with patients with conventional bacteria (p<0·05). For the 19 patients PCR positive for R typhi or Rickettsia spp group, 16 had R typhi but because of insufficient template, we were unable to speciate the other three Rickettsia spp.
Not including children <3 years of age because of difficulty of young children reporting these symptoms.
>20 breaths per min for adults (>15 years) and variable for children depending on their age.
Including patients discharged moribund, extremely likely to have died at home.
The maximum opening pressure that could be measured was 40 cm H2O. Pressures >40 cm H2O were reported as 41 cm H2O.
Figure 1Summary of diagnosed bacterial and fungal infections
Conventional bacteria were defined as Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, or S suis.
Overview of diagnostic findings by disease groups and detection method, excluding patients with evidence of grade 1 or grade 2 co-infections
| PCR (CSF) | 42/1051 (4·0%) | 15/983 (1·5%) | 20/1011 (2·0%) | 6/1014 (0·6%) |
| PCR (blood) | NA | 4/509 (0·8%) | 16/515 (3·1%) | 6/509 (1·2%) |
| Culture (CSF) | 12/1051 (1·0%) | NA | NA | NA |
| Culture (blood) | 8/1051 (0·8%) | 1/62 (1·6%) | 3/62 (4·8%) | 2/646 (0·3%) |
| Total PCR/culture | 42/1051 (4·0%) | 19/1051 (1·9%) | 30/1,051 (2·9%) | 13/1051 (1·2%) |
| Evidence of acute infection | NA | 9/795 (1·1%) | 8/795 (1·0%) | 20/541 (3·7%) |
| Probable or recent infection | NA | 0/795 (0·0%) | 11/795 (1·4%) | 24/541 (4·4%) |
| Four-fold rise/PCR/culture | NA | 28/1051 (2·7%) | 31/1051 (2·9%) | 31/1051 (2·9%) |
Data are the number of positive samples by laboratory investigation (percentages of positives) for the different pathogens. Patients who were positive by more than one method are included for the individual methods but the total is given for infected patients rather than samples. Seroconversion was defined as a four-fold antibody titre rise between admission and convalescent sample, while a high static titre (≥1:12 800) was deemed evidence for infection. CSF=cerebrospinal fluid. IFA=immunofluorescence assay. MAT=microscopic agglutination test.
Mahosot Hospital Microbiology Laboratory participates in the UK NEQAS General Bacteriology and Antimicrobial Susceptibility Testing scheme.
Figure 2Patients who fulfilled WHO criteria for meningitis, meningoencephalitis, AES, or none of these criteria
Meningoencephalitis is defined as fulfilling criteria for both meningitis and AES. AES=acute encephalitis syndrome.
Figure 3Monthly proportions of CNS patients diagnosed with Orientia tsutsugamushi, Rickettsia typhi/Rickettsia spp, Leptospira spp, or so-called conventional bacterial infections among all patients recruited with suspected CNS disease, 2003–11
Total number of patients recruited per month during this study, 2003–11, is shown by bars corresponding to the indicated pathogens. The line represents the mean rainfall (mm) per month in Vientiane during the investigated years. Data from Department of Meteorology and Hydrology, Ministry of Natural Resources and Environment, Lao PDR. *Patient recruitment to this study stopped in November, 2011.
Treatment received by patients with Orientia tsutsugamushi or Rickettsia typhi or Rickettsia spp monoinfections
| Appropriate treatment | 17 | 11 | |
| Doxycycline | 14 | 9 | |
| Chloramphenicol | 2 | 2 | |
| Rifampicin | 1 | .. | |
| Inappropriate treatment | 14 | 17 | |
| Ceftriaxone | 6 | 7 | |
| Ceftriaxone or combination | 5 | 3 | |
| Other | 1 | 3 | |
| Unknown or not treated | 2 | 4 | |
Intravenous azithromycin, doxycycline, and tetracycline are not available in Laos.
Received as part of four fixed-dose combination antituberculosis treatment (4FDC).
Whether rifampicin is effective for murine typhus is unknown.
Combination drug: penicillin (n=2), gentamicin (n=2), gentamicin and ciprofloxacin (n=1), ceftazidime plus ofloxacin plus levofloxacin (n=1).
Penicillin alone (n=2), sulfonamides or antifungal treatment (n=1), amphotericin B/4FDC (n=1).